A detailed history of Twin Tree Management, LP transactions in United Therapeutics Corp stock. As of the latest transaction made, Twin Tree Management, LP holds 6,600 shares of UTHR stock, worth $2.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,600
Previous 34,724 80.99%
Holding current value
$2.37 Million
Previous $11.1 Million 78.62%
% of portfolio
0.0%
Previous 0.03%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$311.04 - $363.55 $1.68 Million - $1.97 Million
-5,406 Reduced 15.57%
29,318 $10.5 Million
Q2 2024

Aug 13, 2024

BUY
$228.26 - $319.04 $7.93 Million - $11.1 Million
34,724 New
34,724 $11.1 Million
Q2 2023

Aug 11, 2023

BUY
$205.19 - $232.99 $220,168 - $249,998
1,073 Added 139.53%
1,842 $406,000
Q1 2023

May 10, 2023

SELL
$212.99 - $276.17 $4.42 Million - $5.73 Million
-20,739 Reduced 96.42%
769 $172,000
Q4 2022

Feb 13, 2023

BUY
$205.95 - $280.43 $3.51 Million - $4.78 Million
17,051 Added 382.57%
21,508 $5.98 Million
Q3 2022

Nov 10, 2022

SELL
$203.3 - $244.17 $2.53 Million - $3.04 Million
-12,438 Reduced 73.62%
4,457 $933,000
Q2 2022

Aug 11, 2022

SELL
$174.81 - $241.14 $6.12 Million - $8.45 Million
-35,026 Reduced 67.46%
16,895 $3.98 Million
Q1 2022

May 11, 2022

BUY
$166.16 - $213.96 $6.14 Million - $7.9 Million
36,928 Added 246.3%
51,921 $9.32 Million
Q4 2021

Feb 10, 2022

BUY
$184.32 - $216.08 $1.74 Million - $2.03 Million
9,417 Added 168.88%
14,993 $3.24 Million
Q3 2021

Nov 12, 2021

SELL
$179.86 - $214.88 $4.44 Million - $5.3 Million
-24,660 Reduced 81.56%
5,576 $1.03 Million
Q2 2021

Aug 12, 2021

SELL
$170.47 - $211.93 $6.43 Million - $8 Million
-37,737 Reduced 55.52%
30,236 $5.43 Million
Q1 2021

May 17, 2021

BUY
$153.94 - $174.85 $5.94 Million - $6.75 Million
38,598 Added 131.4%
67,973 $11.4 Million
Q4 2020

Feb 12, 2021

BUY
$101.87 - $151.79 $2.99 Million - $4.46 Million
29,374 Added 2937400.0%
29,375 $4.46 Million
Q3 2020

Nov 13, 2020

SELL
$99.9 - $121.13 $303,995 - $368,598
-3,043 Reduced 99.97%
1 $0
Q2 2020

Aug 12, 2020

BUY
$92.74 - $125.82 $282,300 - $382,996
3,044 New
3,044 $368,000
Q2 2019

Aug 12, 2019

SELL
$76.06 - $120.81 $389,351 - $618,426
-5,119 Closed
0 $0
Q1 2019

May 10, 2019

BUY
$107.15 - $126.84 $548,500 - $649,293
5,119 New
5,119 $601,000
Q1 2018

May 09, 2018

SELL
$107.21 - $151.94 $632,967 - $897,053
-5,904 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$118.58 - $151.28 $700,096 - $893,157
5,904
5,904 $873,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.